# OnCo record nct05922930 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05922930/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05922930", "NCT05922930" ;
  schema:name "Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer"@en ;
  schema:description "This study tests TROP-2-directed treatment; the registry reports that it is active not recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05922930/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05922930> ;
  onco:status "active" ;
  onco:phase "1/2" ;
  schema:startDate "2023-10-11" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:targets <https://onco.cc/targets/trop2/> .
